Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CombinatoRx Logo
CombinatoRx Growth Score
81
CB Rank
424956
Heat Score
58
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs.
Acquired by
Horizon Discovery Logo
Horizon Discovery
Founded
obfuscation
PrivateSeries C Cambridge, Massachusetts, United States1-10 www.combinatorx.com
Biotechnology
Health Care
Overview

CombinatoRx
Total Funding
obfuscation
Growth Score
81
Heat Score
58

Total Funding
obfuscation
obfuscation
Series C raised
obfuscation
Growth Score81
-6 pts
in past quarter
Heat Score 58
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About CombinatoRx

CB Rank
424956
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs.
Acquired by
Horizon Discovery Logo
Horizon Discovery
Founded
obfuscation
PrivateSeries C Cambridge, Massachusetts, United States1-10 www.combinatorx.com
Biotechnology
Health Care

Funding Rounds

Series C
OBF
in
obfuscation
Series B
OBF
in
obfuscation

Key People

  • Photo of Lee Wrubel
    Lee Wrubel: Associate
    Past Role: Flare Capital Partners, General Partner

Details

Legal Name CombinatoRx, Incorporated
Operating Status Active
Company Type For Profit
Founders  Alexis Borisy, Michael Foley
About the Company
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C
obfuscation
Series C - CombinatoRx Logo
Series C - CombinatoRx
7
obfuscation
Boston Millennia Partners, Canaan PartnersSeries C

Investors

M&A Details

CombinatoRx was acquired by Horizon Discovery on
obfuscation
.
Transaction Name 
CombinatoRx acquired by Horizon Discovery Logo
CombinatoRx acquired by Horizon Discovery
Acquired by 
Horizon Discovery Logo
Horizon Discovery
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Board Members and Advisors 3

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jul 13, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 15, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 26, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 9, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$532KThis year, CombinatoRx is projected to spend $532K on IT, according to Aberdeen.

Active Website Tech Count

5CombinatoRx is actively using 5 technologies for its website, according to BuiltWith. These include Global Site Tag, Gravatar Profiles, and  Outbrain Pixel.

Total IP

16The intellectual property of CombinatoRx includes 16 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is CombinatoRx's headquarters? CombinatoRx is located in Cambridge, Massachusetts, United States.Who invested in CombinatoRx? CombinatoRx has 7 investors including Boston Millennia Partners and  Global Life Science Ventures.When was the last funding round for CombinatoRx? CombinatoRx closed its last funding round on
obfuscation
from a Series C round.How much funding has CombinatoRx raised to date? CombinatoRx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3120884 1)
|